DIN 02483394 — IPRATROPIUM BROMIDE AND SALBUTAMOL SULPHATE INHALATION SOLUTION 0.5 MG; 2.5 MG
IPRATROPIUM BROMIDE AND SALBUTAMOL SULPHATE INHALATION SOLUTION is a solution of Ipratropium / Salbutamol marketed by JUNO PHARMA CANADA INC.. The full Ipratropium / Salbutamol monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02483394
- Brand name
- IPRATROPIUM BROMIDE AND SALBUTAMOL SULPHATE INHALATION SOLUTION
- Active ingredient
- Ipratropium / Salbutamol
- Strength
- 0.5 MG; 2.5 MG
- Dosage form
- SOLUTION
- Route
- INHALATION
- Manufacturer
- JUNO PHARMA CANADA INC.
- Health Canada status
- MARKETED
- Drug class
- Anticholinergic bronchodilator / short-acting beta2-agonist combination
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Ipratropium / Salbutamol products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02266393 | APO-SALVENT-IPRAVENT STERULES | 2.5 MG; 0.5 MG | SOLUTION | APOTEX INC | DORMANT |
| 02419106 | COMBIVENT RESPIMAT | 100 MCG; 20 MCG | SOLUTION | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | MARKETED |
| 02272695 | TEVA-COMBO STERINEBS | 2.5 MG; 0.5 MG | SOLUTION | TEVA CANADA LIMITED | MARKETED |